Neos therapeutics, inc. (NEOS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
ASSETS
Current Assets:
Cash and cash equivalents

27,858

16,830

23,284

25,757

32,760

46,478

16,555

18,318

24,777

31,969

43,398

57,362

43,661

24,352

43,489

41,886

42,392

90,763

102,896

25,631

13,343

Short-term investments

3,992

8,064

1,992

4,494

7,205

-

-

9,722

12,444

18,448

23,089

21,262

10,571

15,430

16,547

38,232

33,730

-

-

-

3,000

Accounts receivable, net of allowances for chargebacks and cash discounts of $3,295 and $4,848, respectively

20,782

26,563

28,877

20,144

23,222

27,801

20,338

17,977

19,642

13,671

8,619

5,669

11,852

6,135

4,263

5,659

6,669

3,903

50

2,096

367

Inventories

10,218

11,010

11,676

12,374

11,276

10,367

11,974

12,713

13,399

11,732

9,992

6,080

5,592

5,542

5,683

4,427

2,501

2,520

2,661

1,703

2,031

Prepaid expenses and other current assets

-

-

-

-

-

4,032

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred contract sales organization fees

-

-

-

-

-

-

-

-

-

-

70

312

623

720

-

525

4,772

-

-

-

-

Other current assets

2,904

4,092

1,757

1,811

2,555

-

1,175

1,336

2,841

3,575

2,760

2,376

2,356

2,519

1,980

1,207

3,070

1,058

819

235

264

Total current assets

65,754

66,559

67,586

64,580

77,018

88,678

50,042

60,066

73,103

79,395

87,928

93,061

74,655

54,698

71,962

91,936

93,134

98,244

106,426

29,665

19,005

Property and equipment, net

7,014

7,345

7,517

7,636

7,532

7,914

8,047

8,269

8,173

8,203

8,323

8,223

6,953

7,076

6,952

6,848

5,403

5,124

5,210

5,334

5,831

Operating lease right-of-use assets

2,920

3,044

3,161

3,274

3,381

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

12,139

12,543

13,187

13,619

14,016

14,616

15,042

15,507

15,931

16,348

-

-

-

17,647

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

16,739

16,879

15,189

-

15,969

16,360

16,772

16,672

17,046

17,420

18,167

Other assets

1,266

1,382

304

149

149

149

149

150

149

162

192

185

2,219

150

2,552

2,564

2,545

2,470

2,427

3,471

2,227

Total assets

89,093

90,873

91,755

89,258

102,096

111,357

73,280

83,992

97,356

104,108

113,182

118,348

99,016

79,571

97,435

117,708

117,854

122,510

131,109

55,890

45,230

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
Accounts payable

13,033

6,650

6,548

6,556

8,552

12,730

7,503

6,060

10,662

11,460

10,706

8,290

6,985

7,798

7,808

3,299

3,469

4,824

2,376

1,333

1,257

Contract sales organization payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,874

-

-

-

-

Accrued expenses

30,556

40,188

37,848

33,684

34,118

35,818

29,947

34,128

28,580

20,944

9,385

8,414

7,065

7,773

7,860

9,189

6,205

3,141

5,086

2,430

2,715

Current portion of operating lease liabilities

707

681

638

606

571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term line of credit

8,569

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt

15,534

15,836

16,108

16,372

-

8,557

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

9,327

6,893

4,933

-

2,558

2,614

-

-

-

-

-

Current portion of long-term debt

-

-

-

-

8,615

-

16,019

15,983

948

896

6,949

7,022

6,996

4,921

3,188

1,745

2,336

7,973

5,775

3,257

1,653

Total current liabilities

68,399

63,355

61,142

57,218

51,856

57,105

53,469

56,171

40,190

33,300

36,367

30,619

25,979

20,492

21,414

16,847

17,884

15,938

13,237

7,020

5,625

Long-Term Liabilities:
Long-term debt, net of current portion

29,422

29,099

28,788

28,489

-

43,217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt, net of current portion

-

-

-

-

43,266

-

43,892

43,932

58,973

58,938

58,970

59,001

59,010

58,599

58,524

58,576

31,786

26,271

28,579

31,198

23,121

Operating lease liabilities

3,067

3,254

3,434

3,608

3,775

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

1,231

1,135

1,239

1,373

1,888

2,017

1,367

1,311

1,474

1,660

1,884

2,086

-

-

-

-

-

-

-

-

-

Earnout liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

355

257

210

214

353

356

756

Net gain on sale leaseback

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

132

339

547

760

967

1,383

Deferred rent

-

-

-

-

-

989

1,012

1,036

1,059

1,083

1,106

1,128

1,151

1,174

1,184

1,194

1,192

1,166

1,163

1,172

1,189

Other long-term liabilities

154

160

180

182

183

184

177

178

179

180

155

198

266

272

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,934

1,789

Total long-term liabilities

33,874

33,648

33,641

33,652

49,112

46,407

46,448

46,457

61,685

61,861

62,115

62,413

60,427

60,045

60,123

60,159

33,527

28,198

30,855

37,627

28,238

Redeemable Preferred Stock, $0.001 par value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

104,249

90,149

Stockholders' (Deficit) Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued or outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value, 100,000,000 shares authorized at March 31, 2020 and December 31, 2019; 49,777,756 and 49,743,955 shares issued and outstanding, respectively, at March 31, 2020; 49,766,472 and 49,732,671 shares issued and outstanding, respectively, at December 31, 2019

50

50

50

50

50

50

30

29

29

29

28

27

23

16

16

16

16

16

16

1

1

Treasury stock, at cost, 33,801 shares at March 31, 2020 and December 31, 2019

352

352

352

352

352

352

352

352

352

352

232

232

-

232

-

-

-

-

-

-

-

Treasury stock, at cost, 18,906 shares at March 31, 2017 and December 31, 2016

-

-

-

-

-

-

-

-

-

-

-

-

232

-

171

171

171

171

-

-

-

Additional paid-in capital

328,956

328,056

327,671

327,035

326,014

325,130

281,331

276,637

275,551

274,584

267,046

261,409

230,030

198,787

197,789

196,757

195,938

195,314

194,682

5,069

4,831

Accumulated deficit

-341,835

-333,885

-330,397

-328,346

-324,583

-316,983

-307,646

-294,951

-279,744

-265,308

-252,141

-235,882

-217,208

-199,536

-181,745

-155,938

-129,399

-116,785

-107,681

-98,076

-83,614

Accumulated other comprehensive income

1

1

-

1

-1

-

-

1

-3

-6

-1

-6

-3

-1

9

38

59

-

-

-

-

Total stockholders’ deficit

-13,180

-6,130

-3,028

-1,612

1,128

7,845

-26,637

-18,636

-4,519

8,947

14,700

25,316

12,610

-966

15,898

40,702

66,443

78,374

87,017

-93,006

-78,782

Total liabilities and stockholders’ deficit

89,093

90,873

91,755

89,258

102,096

111,357

73,280

83,992

97,356

104,108

113,182

118,348

99,016

79,571

97,435

117,708

117,854

122,510

131,109

55,890

45,230